Can insurance deny Wegovy if my BMI is 32?

Yes — but a BMI of 32 meets the FDA indication for Wegovy (BMI ≥30, or ≥27 with a weight-related comorbidity). If your plan denied coverage citing BMI, the denial usually means your documentation did not prove the measured BMI, your plan requires a higher threshold with comorbidity proof, or step therapy was not satisfied. A formal appeal with dated BMI records and a prescriber letter typically addresses BMI-specific denials.

What BMI does my insurance plan require for Wegovy coverage?

Most commercial plans mirror FDA criteria: BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity such as hypertension, prediabetes, dyslipidemia, or obstructive sleep apnea. Some employer plans set stricter thresholds (BMI ≥35) or require documented comorbidities even at BMI 30+. Check your plan's pharmacy benefit document or call your PBM — the exact number is in your formulary criteria, not on the FDA label alone.

How do I prove my BMI for a Wegovy appeal?

Insurers want objective, provider-measured weight and height from a clinical visit within the past 90 days. Include the visit note showing BMI calculation, not just a home scale reading. If your BMI fluctuates, use the most recent in-office measurement. Attach ICD-10 code E66.01 (obesity, BMI 30–39.9) or E66.9 with documented comorbidity codes.

What if my BMI dropped below 30 after starting Wegovy and my renewal was denied?

Maintenance coverage denials are common when patients lose weight below plan thresholds. Your appeal should cite clinical guidelines supporting continued therapy for weight maintenance, document your weight trajectory, and include your prescriber's rationale that discontinuation risks regain. Some plans require periodic reauthorization with current BMI — even if below 30, continued medical necessity for maintenance may still apply.

Does a BMI of 32 with hypertension qualify for Wegovy under most plans?

Yes. BMI ≥27 with a weight-related comorbidity meets FDA criteria and most PBM prior auth guidelines. Your appeal must document the hypertension diagnosis (ICD-10 I10 or I11.x), current blood pressure readings, and any related medications. A generic obesity diagnosis without comorbidity documentation is weaker at BMI 27–32 than at BMI 35+.

How long do I have to appeal a Wegovy BMI denial?

ERISA employer plans typically allow 180 days from the denial date. ACA marketplace plans usually allow 60 days. Medicare Part D redetermination is generally 60 days. Write the deadline on your calendar the day you receive the denial — missing it permanently forfeits appeal rights regardless of how strong your BMI documentation is.

Can I request external review if my BMI appeal is denied internally?

Yes. After internal appeal denial, most plans must offer external review by an independent reviewer. Under ACA §2719, you generally have four months from the internal denial to request external review. External reviewers evaluate whether your documented BMI and comorbidities meet medically accepted standards — they are not bound by arbitrary plan thresholds above FDA criteria.

Can AppealFlow help me write a Wegovy BMI denial appeal?

Yes. AppealFlow.net's free GLP-1 appeal generator drafts a formal letter citing FDA BMI criteria, your specific denial reason, comorbidity documentation requirements, and ERISA appeal rights. Customize it with your clinical details and export to PDF or Word — no account required.

My Insurance Denied Wegovy for BMI 32: What Are My Rights?

By Medical Claims Advocacy Team•12 min read•Updated July 2026

A BMI of 32 meets the FDA indication for Wegovy — yet insurers deny coverage at this level more often than patients expect. Your appeal rights under ERISA and the ACA let you challenge the denial with dated clinical measurements, comorbidity documentation, and a formal letter of medical necessity from your prescriber.

Why Insurers Deny Wegovy at BMI 32 Despite FDA Approval

Key Takeaway: BMI 32 qualifies under FDA labeling, but your plan may require comorbidity proof, step therapy completion, or in-office measurement within 90 days. The denial reason on your letter — not your BMI alone — determines your appeal strategy.

I review dozens of GLP-1 denials each month, and BMI-related rejections at the 30–34 range are among the most frustrating for patients. You meet the clinical threshold. Your doctor agrees. Yet the PBM sends a denial citing “does not meet plan criteria.”

The four most common BMI-specific denial patterns I see:

Undocumented BMI: Your prior auth listed a self-reported weight or an outdated measurement from 6+ months ago. Insurers require provider-measured height and weight.
Comorbidity gap at BMI 27–32: Some plans require documented hypertension, prediabetes, OSA, or dyslipidemia when BMI is below 35 — even though FDA approval starts at BMI 30 without comorbidity.
Step therapy not satisfied: The denial has nothing to do with BMI — your plan requires failed trials of metformin, phentermine, or lifestyle programs first.
Formulary exclusion: Your employer plan excludes all GLP-1 weight-loss drugs. BMI documentation will not help — you need a formulary exception citing medical necessity.

Pull your denial letter and find the specific reason code. Cross-reference it with your plan's pharmacy benefit criteria — usually available on your PBM portal or by calling member services.

Your Legal Rights When Coverage Is Denied at Qualifying BMI

Key Takeaway: ERISA §503 and ACA §2719 give you the right to a full internal appeal, access to documents used in the denial, and external review by an independent party. These rights apply regardless of your BMI — as long as you file before the deadline.

If your plan is employer-sponsored and governed by ERISA, you have specific protections:

180-day appeal window from the date on your denial letter or EOB
Right to review your claim file — every document the insurer used to deny you
Written decision requirement — the insurer must explain why your appeal was approved or denied
External review after internal denial by a reviewer not employed by your insurer

ACA marketplace plans follow similar rules with a 60-day internal appeal window and mandatory external review rights. Medicare Part D uses a separate redetermination and reconsideration process — 60 days for the first level.

None of these rights activate automatically. You must file a formal appeal — not just resubmit the same prior auth form through CoverMyMeds.

Step-by-Step: How to Appeal a Wegovy BMI Denial

Key Takeaway: File before the deadline, attach a complete clinical packet with in-office BMI measurement, and request a written decision. Incomplete appeals at qualifying BMI levels fail more often than appeals at higher BMI with better documentation.

Confirm your appeal deadline. Write it on your calendar the day you receive the denial. ERISA: 180 days. ACA marketplace: 60 days.
Schedule an in-office weigh-in. If your last documented BMI is older than 90 days, get a fresh measurement from your prescriber before filing.
Request your complete claim file. Under ERISA §503, ask for all documents used in the denial decision — including the plan's internal BMI criteria.
Get a detailed letter of medical necessity. Your prescriber must cite your measured BMI (e.g., 32.4), ICD-10 E66.01, FDA NDA 215256 criteria, and any comorbidities with supporting labs.
Gather comorbidity records. HbA1c, blood pressure logs, lipid panel, sleep study results — anything that strengthens the case at BMI 30–34.
Write and submit your formal appeal. Address the specific denial code, cite your legal appeal rights, and list every attachment.
Submit through the correct PBM portal. Confirm receipt — do not rely on fax alone.
Follow up at 14 and 30 days. Document every call with date, representative name, and reference number.

Weak vs. Strong BMI Appeal Language (Before & After)

Key Takeaway: Insurer medical directors approve BMI appeals with objective measurements and ICD-10 codes — not self-reported weight or emotional statements about body image.

❌ Weak Statement	✅ Strong Statement
“My BMI is 32 and I need Wegovy. The scale at home says I qualify.”	“Provider-measured BMI 32.4 on 07/15/2026 (height 5'6", weight 201 lbs). ICD-10 E66.01. Meets FDA Wegovy indication per NDA 215256 (BMI ≥30). Attached: office visit note with calculated BMI.”
“I have health problems related to my weight so I should get coverage.”	“BMI 32.1 with documented comorbidities: hypertension (I10, BP 148/94 on 07/10/2026), prediabetes (E11.65, HbA1c 6.3%), and OSA (G47.33, AHI 22 on sleep study 06/2026). Meets plan criteria for BMI ≥27 with weight-related comorbidity.”
“Please approve Wegovy. My BMI is high enough under FDA rules.”	“I formally request internal appeal under ERISA §503. Denial code PA-BMI-02 cited insufficient BMI documentation. Attached: in-office measurement (BMI 32.4), prescriber letter of medical necessity, and step therapy records per plan Section 4.1.”

Need a Wegovy BMI Appeal Letter Drafted?

AppealFlow's free GLP-1 generator creates a regulation-informed letter citing FDA BMI criteria, comorbidity documentation, and ERISA rights — ready in under 60 seconds.

Generate GLP-1 Appeal Letter

Documenting BMI and Comorbidities for Your Appeal Packet

Key Takeaway: At BMI 32, comorbidity documentation often makes the difference between approval and denial. Include at least one weight-related condition with supporting clinical evidence — even though FDA approval does not require it at BMI ≥30.

Your appeal packet should contain five components:

In-office BMI measurement within 90 days — visit note with height, weight, and calculated BMI
Prescriber letter of medical necessity addressing the specific denial code and citing FDA criteria
ICD-10 codes: E66.01 (obesity BMI 30–39.9) plus comorbidity codes (I10, E11.65, G47.33, E78.5)
Lab results and specialist notes supporting comorbidity claims
The denial letter itself with member ID, claim number, and denial reason code

A common mistake at BMI 30–34: patients assume BMI alone is enough. Many PBMs apply stricter internal thresholds or require comorbidity proof in this range. Over-document rather than under-document.

Submitting Through PBM Portals (CoverMyMeds, Express Scripts, OptumRx)

Key Takeaway: BMI denials are processed through your Pharmacy Benefit Manager. Submitting only by mail while your plan requires portal upload is a common reason appeals get lost or marked incomplete.

Platform	Used By	Appeal Submission
CoverMyMeds	Multiple PBMs; prescriber-initiated PA	Prescriber submits via key code; attach BMI records and appeal letter
Express Scripts	Cigna, some BCBS plans	Member portal → Pharmacy → Appeals; fax backup to number on denial
OptumRx	UnitedHealthcare, some employer plans	OptumRx.com → Prior Authorization → File Appeal with clinical attachments
Caremark (CVS)	Aetna, CVS Health plans	Caremark.com → Coverage & Claims → Appeal a Decision

Ask your prescriber's office to upload the in-office BMI visit note through the same portal used for the original prior auth. If they initiated the PA through CoverMyMeds, the appeal should go through CoverMyMeds too — with your formal appeal letter attached.

Edge Cases: BMI Fluctuation, Maintenance Denials, and Plan Exclusions

Key Takeaway: BMI-related denials do not always happen at initial authorization. Maintenance renewals, weight loss below threshold, and employer formulary exclusions require different appeal strategies.

Weight loss below BMI 30 on renewal: If you started Wegovy at BMI 32 and dropped to BMI 28, your plan may deny continuation. Appeal with your prescriber's maintenance rationale, weight trajectory data, and clinical guidelines supporting continued therapy to prevent regain.

BMI measured differently: Some plans use waist circumference or body fat percentage as additional criteria. If your appeal cites BMI but the plan evaluated waist-to-hip ratio, address both metrics in your resubmission.

Employer formulary exclusion: If your plan excludes all GLP-1 weight-loss drugs, a BMI appeal alone will not work. You need a formulary exception request citing medical necessity and documented failure of covered alternatives.

Common myth: Losing 5–10 pounds before filing your appeal to “strengthen” your case can backfire if you drop below plan thresholds. File with your current documented BMI — do not delay while trying to gain or lose weight strategically.

Realistic Timelines and Success Rates at BMI 32

Key Takeaway: BMI 32 appeals with complete in-office documentation succeed roughly 45–55% on first internal submission. Appeals relying on self-reported weight succeed less than 15%. Plan for 30 days standard, 72 hours expedited.

I want to be direct: qualifying BMI does not guarantee approval. Insurers approve when your documentation matches their internal criteria — which may be stricter than FDA labeling. Your appeal letter frames the clinical record and invokes your legal rights.

Expedited appeal: 72 hours — use if your prescriber certifies delay poses serious health risk
Standard internal appeal: 30 days from receipt of complete documentation
External review: 45–60 days after internal denial

Five Mistakes That Kill BMI 32 Wegovy Appeals

Key Takeaway: The most common failure at qualifying BMI is insufficient documentation — not insufficient weight. Avoid self-reported measurements and generic prescriber notes.

Using home scale weight instead of in-office measurement. Insurers reject self-reported BMI routinely.
Ignoring comorbidity requirements at BMI 30–34. Over-document weight-related conditions even when FDA criteria do not require them.
Resubmitting the PA form instead of filing a formal appeal. After denial, invoke appeal rights explicitly.
Missing the deadline. Calendar it the day you receive the denial — no exceptions.
Stopping after internal denial. External review is your strongest remaining option and many patients never request it.

Frequently Asked Questions

Answers to the most common Wegovy BMI denial questions from patients and providers.

Generate Your Free Wegovy BMI Appeal Letter

AppealFlow.net drafts a formal, legally grounded appeal letter citing FDA BMI criteria, comorbidity documentation, and ERISA rights — edit it live, then download as PDF or Word. No account required.

Generate Free Appeal Letter GLP-1 Specialized Tool

100% Free
No Signup
PDF & Word Export

Disclaimer: This article is for educational purposes only and does not constitute medical or legal advice. AppealFlow.net is not a healthcare provider or law firm. Success rates cited are estimates based on industry advocacy data and vary by plan. Always review appeal letters with your prescriber before submission. For medical emergencies, call 911. See our full disclaimer.